Cargando…

Prognostic Factors Five Years After Enucleation for Uveal Melanoma

PURPOSE: A subgroup of uveal melanoma (UM) gives rise to metastases at a late stage. Our objective was to identify patient and tumor characteristics that are associated with UM-related death in patients who survived 5 years following enucleation. METHODS: A retrospective analysis was performed in 58...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogrusöz, Mehmet, Brouwer, Niels J., de Geus, Stefan J. R., Ly, Long V., Böhringer, Stefan, van Duinen, Sjoerd G., Kroes, Wilma G. M., van der Velden, Pieter A., Haasnoot, Geert W., Marinkovic, Marina, Luyten, Gregorius P. M., Kivelä, Tero T., Jager, Martine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401572/
https://www.ncbi.nlm.nih.gov/pubmed/32186672
http://dx.doi.org/10.1167/iovs.61.3.31
_version_ 1783566591185649664
author Dogrusöz, Mehmet
Brouwer, Niels J.
de Geus, Stefan J. R.
Ly, Long V.
Böhringer, Stefan
van Duinen, Sjoerd G.
Kroes, Wilma G. M.
van der Velden, Pieter A.
Haasnoot, Geert W.
Marinkovic, Marina
Luyten, Gregorius P. M.
Kivelä, Tero T.
Jager, Martine J.
author_facet Dogrusöz, Mehmet
Brouwer, Niels J.
de Geus, Stefan J. R.
Ly, Long V.
Böhringer, Stefan
van Duinen, Sjoerd G.
Kroes, Wilma G. M.
van der Velden, Pieter A.
Haasnoot, Geert W.
Marinkovic, Marina
Luyten, Gregorius P. M.
Kivelä, Tero T.
Jager, Martine J.
author_sort Dogrusöz, Mehmet
collection PubMed
description PURPOSE: A subgroup of uveal melanoma (UM) gives rise to metastases at a late stage. Our objective was to identify patient and tumor characteristics that are associated with UM-related death in patients who survived 5 years following enucleation. METHODS: A retrospective analysis was performed in 583 primary UM cases, enucleated at the Leiden University Medical Center between 1983 and 2013. Univariable and multivariable Cox regression analyses were performed in the total cohort and separately in those surviving more than 5 years (n = 297). RESULTS: In the total cohort, the median age was 62.6 years, and the median tumor diameter was 12.0 mm. Monosomy 3 was detected in 53% of cases and gain of 8q in 47%. In the cohort surviving 5 years, the median age was 59.5 years, and the median tumor diameter was 11.0 mm. Monosomy 3 and gain of 8q were detected in 33% and 31% of cases, respectively. In the total cohort, male gender (P = 0.03), tumor diameter (P < 0.001), mitotic count (P < 0.001), extravascular matrix loops (P = 0.03), extraocular growth (P < 0.001), and gain of 8q (P < 0.001) were independently associated with UM-related death. In patients surviving 5 years after enucleation, univariable analysis revealed that age (P = 0.03), tumor diameter (P < 0.001), monosomy 3 (P = 0.04), and 8q gain (P = 0.003) were associated with subsequent UM-related death. Using a multivariable analysis, only male gender (P = 0.03) and gain of 8q (P = 0.01) remained significant. CONCLUSIONS: Predictors of UM-related death change over time. Among UM patients who survived the initial 5 years following enucleation, male gender and chromosome 8q status were the remaining factors related to UM-related death later on.
format Online
Article
Text
id pubmed-7401572
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-74015722020-08-18 Prognostic Factors Five Years After Enucleation for Uveal Melanoma Dogrusöz, Mehmet Brouwer, Niels J. de Geus, Stefan J. R. Ly, Long V. Böhringer, Stefan van Duinen, Sjoerd G. Kroes, Wilma G. M. van der Velden, Pieter A. Haasnoot, Geert W. Marinkovic, Marina Luyten, Gregorius P. M. Kivelä, Tero T. Jager, Martine J. Invest Ophthalmol Vis Sci Anatomy and Pathology/Oncology PURPOSE: A subgroup of uveal melanoma (UM) gives rise to metastases at a late stage. Our objective was to identify patient and tumor characteristics that are associated with UM-related death in patients who survived 5 years following enucleation. METHODS: A retrospective analysis was performed in 583 primary UM cases, enucleated at the Leiden University Medical Center between 1983 and 2013. Univariable and multivariable Cox regression analyses were performed in the total cohort and separately in those surviving more than 5 years (n = 297). RESULTS: In the total cohort, the median age was 62.6 years, and the median tumor diameter was 12.0 mm. Monosomy 3 was detected in 53% of cases and gain of 8q in 47%. In the cohort surviving 5 years, the median age was 59.5 years, and the median tumor diameter was 11.0 mm. Monosomy 3 and gain of 8q were detected in 33% and 31% of cases, respectively. In the total cohort, male gender (P = 0.03), tumor diameter (P < 0.001), mitotic count (P < 0.001), extravascular matrix loops (P = 0.03), extraocular growth (P < 0.001), and gain of 8q (P < 0.001) were independently associated with UM-related death. In patients surviving 5 years after enucleation, univariable analysis revealed that age (P = 0.03), tumor diameter (P < 0.001), monosomy 3 (P = 0.04), and 8q gain (P = 0.003) were associated with subsequent UM-related death. Using a multivariable analysis, only male gender (P = 0.03) and gain of 8q (P = 0.01) remained significant. CONCLUSIONS: Predictors of UM-related death change over time. Among UM patients who survived the initial 5 years following enucleation, male gender and chromosome 8q status were the remaining factors related to UM-related death later on. The Association for Research in Vision and Ophthalmology 2020-03-18 /pmc/articles/PMC7401572/ /pubmed/32186672 http://dx.doi.org/10.1167/iovs.61.3.31 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Anatomy and Pathology/Oncology
Dogrusöz, Mehmet
Brouwer, Niels J.
de Geus, Stefan J. R.
Ly, Long V.
Böhringer, Stefan
van Duinen, Sjoerd G.
Kroes, Wilma G. M.
van der Velden, Pieter A.
Haasnoot, Geert W.
Marinkovic, Marina
Luyten, Gregorius P. M.
Kivelä, Tero T.
Jager, Martine J.
Prognostic Factors Five Years After Enucleation for Uveal Melanoma
title Prognostic Factors Five Years After Enucleation for Uveal Melanoma
title_full Prognostic Factors Five Years After Enucleation for Uveal Melanoma
title_fullStr Prognostic Factors Five Years After Enucleation for Uveal Melanoma
title_full_unstemmed Prognostic Factors Five Years After Enucleation for Uveal Melanoma
title_short Prognostic Factors Five Years After Enucleation for Uveal Melanoma
title_sort prognostic factors five years after enucleation for uveal melanoma
topic Anatomy and Pathology/Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401572/
https://www.ncbi.nlm.nih.gov/pubmed/32186672
http://dx.doi.org/10.1167/iovs.61.3.31
work_keys_str_mv AT dogrusozmehmet prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT brouwernielsj prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT degeusstefanjr prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT lylongv prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT bohringerstefan prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT vanduinensjoerdg prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT kroeswilmagm prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT vanderveldenpietera prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT haasnootgeertw prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT marinkovicmarina prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT luytengregoriuspm prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT kivelaterot prognosticfactorsfiveyearsafterenucleationforuvealmelanoma
AT jagermartinej prognosticfactorsfiveyearsafterenucleationforuvealmelanoma